Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
Briggs CA, Pollock NJ, Frail DE, Paxson CL, Rakowski RF, Kang CH, Kebabian JW.
???displayArticle.abstract???
1. A cloned 5-HT1C receptor expressed in Xenopus laevis oocytes was used to characterize the action of four dopamine D1-selective benzazepines at the 5-HT1C receptor. Additionally, the apparent binding of the D1-selective benzazepines to 5-HT1C receptors was measured in the choroid plexus of the pig. 2. In voltage-clamped oocytes expressing the cloned 5-HT1C receptor, 5-hydroxytryptamine (5-HT) elicited a characteristic inward current response with an EC50 of 13 nM. SCH 23390 acted as a stereoselective agonist (or partial agonist) with an EC50 of about 550 nM. SKF 38393 (1 microM-1 mM), SKF 77434 (100 microM), and SKF 82958 (100 microM) also acted as agonists (or partial agonists) at the cloned 5-HT1C receptor. SKF 38393 was not stereoselective at the 5-HT1C receptor. 3. The response to SCH 23390 activated slowly and, although the response contained many oscillations characteristic of the activation of the phosphatidylinositol signal transduction system, SCH 23390 rarely elicited the rapid spike-like response seen routinely in response to 5-HT. However, the responses to SKF 38393, SKF 77434, and SKF 82958 were identical in appearance to the response to 5-HT, except that the responses to the benzazepines were smaller. These comparisons were made by applying both a benzazepine and 5-HT to each individual oocyte expressing the cloned 5-HT1C receptor. 4. Consistent with the responses measured in oocytes, SCH 23390 bound stereoselectively to 5-HT1C receptors in the choroid plexus of the pig (Ki = 6.3 nM), and SKF 38393 bound non-stereoselectively with lower affinity (Ki = 2.0-2.2 microM).5. It is concluded that while these benzazepines demonstrate selectivity for the dopamine D1 receptor, they also can act as agonists or partial agonists at the 5-HT1c receptor in situ and as expressed in Xenopus oocytes. The oocyte expression system is useful for studies of the functional pharmacology of these 5-HTic receptors. Information about the pharmacological actions and variations in stereoselectivity among dopamine and 5-HT receptors should be of interest in modelling the interactions of ligands with these G-protein coupled receptors, and in the testing of such models through receptor mutagenesis.
Andersen,
A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum.
1985, Pubmed
Andersen,
A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum.
1985,
Pubmed Berridge,
Inositol 1,4,5-trisphosphate-induced calcium mobilization is localized in Xenopus oocytes.
1989,
Pubmed
,
Xenbase Billard,
Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
1984,
Pubmed Bischoff,
The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.
1986,
Pubmed Bischoff,
Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome.
1988,
Pubmed Briggs,
Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
1991,
Pubmed Conn,
A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover.
1986,
Pubmed Dawson,
Quantitative autoradiographic localization of D-1 dopamine receptors in the rat brain: use of the iodinated ligand [125I]SCH 23982.
1986,
Pubmed De Keyser,
[3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes.
1989,
Pubmed De Keyser,
D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation.
1988,
Pubmed Dumont,
Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals.
1972,
Pubmed
,
Xenbase Felder,
Dopamine-1-mediated stimulation of phospholipase C activity in rat renal cortical membranes.
1989,
Pubmed Felder,
The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase.
1989,
Pubmed Hartig,
Molecular biology of 5-HT receptors.
1989,
Pubmed Hess,
Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
1986,
Pubmed Hicks,
5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain.
1984,
Pubmed Hoffman,
Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain.
1989,
Pubmed Hoyer,
5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization.
1989,
Pubmed Hoyer,
[125I]SCH 23982, a 'selective' D-1 receptor antagonist, labels with high affinity 5-HT1C sites in pig choroid plexus.
1988,
Pubmed Hoyer,
Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
1985,
Pubmed Hoyer,
[125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding.
1986,
Pubmed Hoyer,
Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.
1986,
Pubmed Hoyer,
Molecular pharmacology and biology of 5-HT1C receptors.
1988,
Pubmed Hyttel,
SCH 23390 - the first selective dopamine D-1 antagonist.
1983,
Pubmed Jenck,
5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.
1990,
Pubmed Julius,
Molecular characterization of a functional cDNA encoding the serotonin 1c receptor.
1988,
Pubmed
,
Xenbase LaHoste,
Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
1990,
Pubmed Lester,
Heterologous expression of excitability proteins: route to more specific drugs?
1988,
Pubmed Lübbert,
cDNA cloning of a serotonin 5-HT1C receptor by electrophysiological assays of mRNA-injected Xenopus oocytes.
1987,
Pubmed
,
Xenbase Lübbert,
Rat brain 5-HT1C receptors are encoded by a 5-6 kbase mRNA size class and are functionally expressed in injected Xenopus oocytes.
1987,
Pubmed
,
Xenbase Mahan,
Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes.
1990,
Pubmed
,
Xenbase McQuade,
Serotonergic component of SCH 23390: in vitro and in vivo binding analyses.
1988,
Pubmed Mengod,
The distribution and cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution.
1990,
Pubmed Molineaux,
5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system.
1989,
Pubmed Molloy,
Assessment of grooming and other behavioural responses to the D-1 dopamine receptor agonist SK & F 38393 and its R- and S-enantiomers in the intact adult rat.
1987,
Pubmed Nicklaus,
[3H]SCH 23390 labels both dopamine-1 and 5-hydroxytryptamine1c receptors in the choroid plexus.
1988,
Pubmed Niznik,
Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor.
1986,
Pubmed Ohlstein,
SCH 23390 and SK&F 83566 are antagonists at vascular dopamine and serotonin receptors.
1985,
Pubmed Parker,
Localized all-or-none calcium liberation by inositol trisphosphate.
1990,
Pubmed
,
Xenbase Pazos,
Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors.
1984,
Pubmed Pazos,
The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site.
1984,
Pubmed Peroutka,
Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex.
1986,
Pubmed Peroutka,
5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization.
1988,
Pubmed Rubinstein,
Further evidence against the coupling of dopamine receptors to phosphoinositide hydrolysis in rat striatum.
1990,
Pubmed Sakai,
Dopamine receptors expressed in the Xenopus oocytes injected with bovine striatal mRNA.
1990,
Pubmed
,
Xenbase Schmidt,
5-Hydroxytryptamine receptor "families".
1989,
Pubmed Sigel,
Use of Xenopus oocytes for the functional expression of plasma membrane proteins.
1990,
Pubmed
,
Xenbase Skarsfeldt,
SCH 23390--a selective dopamine D-1 receptor antagonist with putative 5-HT1 receptor agonistic activity.
1988,
Pubmed Smith,
Expression of rat mRNA coding for hormone-stimulated adenylate cyclase in Xenopus oocytes.
1987,
Pubmed
,
Xenbase Snutch,
The use of Xenopus oocytes to probe synaptic communication.
1988,
Pubmed
,
Xenbase Sumikawa,
Messenger RNA from rat brain induces noradrenaline and dopamine receptors in Xenopus oocytes.
1984,
Pubmed
,
Xenbase Undie,
Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain.
1990,
Pubmed Vasilets,
Activation of protein kinase C by phorbol ester induces downregulation of the Na+/K(+)-ATPase in oocytes of Xenopus laevis.
1990,
Pubmed
,
Xenbase Yagaloff,
125I-lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells.
1985,
Pubmed